By a News Reporter-Staff News Editor at Pharma Business Week — According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for “BICILLIN” by Matthew A. Pater, representing Pfizer. This application was made available to the public on June 30, 2014 (see also Trademarks).
The international trademark goods and services class code for this trademark application is 005.
The serial number for this application is 78284102.
As submitted by the applicant, this trademark application relates to the following goods and services: Dibenzylethylenediamine dipencillin.
The owner/registrar information for this application is: Matthew A. Pater, Pfizer, 235 East 42nd Street, New York NY 10017.
Keywords for this news article include: Pharmaceutical Companies, Pfizer, Trademarks.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC
Trademark Application for “BICILLIN” Filed by Pfizer
By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for
- 1 min Read
- 07.9.2014
They're now able to use AI to assess data generated by everything from drills and trucks to conveyors and ships.
Trucking is one of the purest forms of economic supply and demand out there.
A weekly five-point roundup of critical events in the energy transition and the implications of climate change for business and finance.
I’m pro-renewable energy. But I’m against worshiping any technology and blindly glossing over its drawbacks.
The company is facing tons of issues. But are these temporary or more permanent?
Thanks to the leap AI’s made this past year, you can now clone any voice from a 30-second clip.
